Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
CALL
Crown Holdings
CCK
$12.9B
| $4.51M | ﹤0.01% |
48,900
-11,400
| -19% | -$1.22M |
|
|
LOVE
3902
CALL
LoveSac
LOVE
$253M
| $4.51M | ﹤0.01% |
163,900
+106,600
| +186% | +$4.14M |
|
3903
PUT
iShares Core S&P Mid-Cap ETF
IJH
$129B
| $4.5M | ﹤0.01% |
99,500
+68,000
| +216% | +$3.36M |
|
3904
PUT
Bread Financial
BFH
$4.58B
| $4.5M | ﹤0.01% |
121,400
-51,500
| -30% | -$2.62M |
|
3905
Smith & Nephew
SNN
$12.5B
| $4.5M | ﹤0.01% |
161,109
-111,483
| -41% | -$3.47M |
|
|
AVAN
3906
DELISTED
Avanti Acquisition Corp.
AVAN
| $4.5M | ﹤0.01% |
453,643
-1,538,096
| -77% | -$15.2M |
|
|
DCH
3907
CALL
Dauch Corp
DCH
$1.6B
| $4.5M | ﹤0.01% |
597,000
+519,900
| +674% | +$3.91M |
|
|
SAFE
3908
Safehold
SAFE
$1.08B
| $4.49M | ﹤0.01% |
67,317
+9,353
| +16% | +$788K |
|
3909
PUT
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.3B
| $4.49M | ﹤0.01% |
257,000
-10,900
| -4% | -$205K |
|
3910
CALL
Invesco S&P 500 Low Volatility ETF
SPLV
$7.23B
| $4.49M | ﹤0.01% |
72,400
+33,500
| +86% | +$2.17M |
|
3911
CALL
Icon
ICLR
$12.6B
| $4.49M | ﹤0.01% |
20,700
-10,800
| -34% | -$2.42M |
|
3912
CALL
Herbalife
HLF
$1.29B
| $4.49M | ﹤0.01% |
219,300
+36,500
| +20% | +$902K |
|
|
MRTX
3913
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.48M | ﹤0.01% |
66,800
+15,500
| +30% | +$986K |
|
|
HSKA
3914
DELISTED
Heska Corp
HSKA
| $4.48M | ﹤0.01% |
47,446
-6,662
| -12% | -$719K |
|
|
HOLX
3915
CALL
DELISTED
Hologic
HOLX
| $4.48M | ﹤0.01% |
64,600
-44,400
| -41% | -$3.3M |
|
|
NKLA
3916
PUT
DELISTED
Nikola Corporation Common Stock
NKLA
| $4.48M | ﹤0.01% |
31,343
-8,750
| -22% | -$1.79M |
|
3917
CALL
Extra Space Storage
EXR
$31.2B
| $4.47M | ﹤0.01% |
26,300
-15,800
| -38% | -$2.93M |
|
3918
Zimmer Biomet
ZBH
$19.2B
| $4.47M | ﹤0.01% |
+42,583
| New | +$5.05M |
|
|
FYBR
3919
CALL
DELISTED
Frontier Communications
FYBR
| $4.47M | ﹤0.01% |
190,000
+74,300
| +64% | +$1.9M |
|
3920
Vanguard US Value Factor ETF
VFVA
$945M
| $4.47M | ﹤0.01% |
+48,970
| New | +$4.95M |
|
3921
Cactus
WHD
$5.88B
| $4.47M | ﹤0.01% |
111,014
+80,932
| +269% | +$4.07M |
|
3922
Kaiser Aluminum
KALU
$2.97B
| $4.46M | ﹤0.01% |
56,366
+51,971
| +1,183% | +$4.86M |
|
3923
PUT
Vanguard Morningstar Value ETF
VTV
$194B
| $4.46M | ﹤0.01% |
33,800
+7,600
| +29% | +$1.07M |
|
3924
CALL
PTC
PTC
$16.2B
| $4.46M | ﹤0.01% |
41,900
+11,900
| +40% | +$1.28M |
|
3925
Neogen
NEOG
$2.54B
| $4.45M | ﹤0.01% |
184,890
+144,765
| +361% | +$3.88M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.